Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Posterior polymorphous corneal dystrophy (PPCD) is a rare mild subtype of posterior corneal dystrophy characterized by small aggregates of apparent vesicles bordered by a gray haze at the level of Descemet membrane, generally with no effect on vision.
Biomarker and diagnostic research for posterior polymorphous corneal dystrophy has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions and gene therapy. Research is primarily sponsored by academic and government institutions.
17 publications have been identified in PubMed for posterior polymorphous corneal dystrophy. Research spans Case Report / Case Series (47%), Basic Science / Preclinical (20%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:47 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 3 | 20% |
Testing and diagnosis research | 2 | 13% |
Research summaries | 2 | 13% |
Disease patterns and progression | 1 | 7% |
Qiu J (2026). [PMID: 42147942](https://pubmed.ncbi.nlm.nih.gov/42147942/). *Quant Imaging Med Surg*. [Diagnostic / Biomarker]
Yuan Y (2026). [PMID: 41840915](https://pubmed.ncbi.nlm.nih.gov/41840915/). *Genesis (New York, N.Y. : 2000)*. [Case Report / Case Series]
Balal S (2026). [PMID: 41569999](https://pubmed.ncbi.nlm.nih.gov/41569999/). *European journal of ophthalmology*. [Basic Science / Preclinical]
Flockerzi E (2026). [PMID: 41248687](https://pubmed.ncbi.nlm.nih.gov/41248687/). *Klinische Monatsblatter fur Augenheilkunde*. [Review / Meta-Analysis]
Kaur K (2026). [PMID: 36256774](https://pubmed.ncbi.nlm.nih.gov/36256774/). *Unknown Journal*. [Diagnostic / Biomarker]
Tas MD (2026). [PMID: 42159160](https://pubmed.ncbi.nlm.nih.gov/42159160/). *Clin Exp Optom*. [Case Report / Case Series]
Lin Q (2025). [PMID: 40547359](https://pubmed.ncbi.nlm.nih.gov/40547359/). *Frontiers in genetics*. [Case Report / Case Series]
Liskova P (2025). [PMID: 40079222](https://pubmed.ncbi.nlm.nih.gov/40079222/). *Clinical & experimental ophthalmology*. [Review / Meta-Analysis]
Bartsch S (2025). [PMID: 40558505](https://pubmed.ncbi.nlm.nih.gov/40558505/). *Cells*. [Basic Science / Preclinical]
Sharma A (2025). [PMID: 40234074](https://pubmed.ncbi.nlm.nih.gov/40234074/). *BMJ case reports*. [Epidemiology / Natural History]